What is the current price of AYA.AX stock?

AYA.AX stock trades at **A$4.15** after hours on 26 Jan 2026. The intraday range was **A$3.87–A$4.15** with volume **342,272**. Watch the next earnings date on 24 Feb 2026 for updates.

What are the main risks for AYA.AX stock investors?

Main risks include continued negative earnings (**EPS -0.18**), very high valuation multiples, slow revenue conversion, and dependency on clinical adoption. Regulatory and reimbursement delays could also pressure AYA.AX stock performance.

What catalysts could move AYA.AX stock higher?

Catalysts are stronger recurring revenue from Salix, regulatory approvals, published clinical outcomes, and positive results at the 24 Feb 2026 earnings announcement. Contract renewals with hospitals would be a clear positive for AYA.AX stock.

What is Meyka AI's view and forecast for AYA.AX stock?

Meyka AI's forecast model projects **yearly A$7.30**, a **75.98%** implied upside from **A$4.15**. Meyka AI rates the stock **C+ (59.16)** with a **HOLD** suggestion. Forecasts are model-based projections and not guarantees.

AU Stocks

AYA.AX Artrya Limited ASX after hours A$4.15: AI-driven Salix lifts outlook

ByDanny Kontos January 26, 2026January 26, 2026

AYA.AX stock traded after hours at A$4.15 on 26 Jan 2026, holding near the day high after recent momentum. Investors are watching Artrya Limited (ASX) for signs that its AI-powered Salix platform can convert pilot wins into recurring revenue. Key metrics show market cap A$478,210,400.00, EPS -0.18 and a 50-day average price of A$3.93. This note links product traction to valuation and short-term technicals, and highlights the upcoming earnings date on 24 Feb 2026 as a potential catalyst.